Suppliers and packagers for CELESTONE SOLUSPAN

CELESTONE SOLUSPAN

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Organon	CELESTONE SOLUSPAN	betamethasone acetate; betamethasone sodium phosphate	INJECTABLE;INJECTION	014602	NDA	Organon LLC	78206-118-01	1 VIAL, MULTI-DOSE in 1 BOX (78206-118-01) / 5 mL in 1 VIAL, MULTI-DOSE	2021-06-01
Organon	CELESTONE SOLUSPAN	betamethasone acetate; betamethasone sodium phosphate	INJECTABLE;INJECTION	014602	NDA	Sportpharm, Inc. dba Sportpharm	85766-070-05	1 VIAL, MULTI-DOSE in 1 BOX (85766-070-05) / 5 mL in 1 VIAL, MULTI-DOSE	2021-06-01

Suppliers for the Pharmaceutical Drug: CELESTONE SOLUSPAN

Last updated: August 3, 2025

Introduction

The pharmaceutical industry’s reliance on a diversified supply chain underscores the importance of identifying reliable suppliers for specific medications. Celestone Soluspan—a proprietary formulation potentially used for various therapeutic indications—necessitates a comprehensive understanding of its supply landscape. Given the limited publicly available data on Celestone Soluspan, this analysis synthesizes industry insights, regulatory filings, and market intelligence to elucidate the key suppliers involved in its manufacturing, distribution, and raw material sourcing.

Understanding Celestone Soluspan

Before delving into supplier analysis, understanding what Celestone Soluspan encompasses is vital. The drug likely falls into a specialized category, such as a branded formulation for certain indications. Its composition, manufacturing process, and regulatory status influence the supplier network. While exact formulation details remain proprietary or undisclosed publicly, the manufacturing process typically involves active pharmaceutical ingredients (APIs), excipients, and packaging components sourced domestically and internationally.

Major Manufacturers and Contract Manufacturing Organizations (CMOs)

The supply chain for Celestone Soluspan primarily involves brand owners, APIs suppliers, and contract manufacturing organizations (CMOs). Large pharmaceutical companies often outsource production to CMOs, which possess the necessary facilities and regulatory expertise to produce drug substances and finished formulations at scale.

1. Original Brand Owner and Licensed Manufacturers

The patent holder or licensee typically engages with manufacturing partners approved through regulatory channels. Confidentiality agreements usually prevent public disclosure of specific manufacturing sites; however, some companies disclose partnerships through filings or industry releases.

• Celestone Pharmaceuticals (hypothetical name for illustration) might directly oversee the manufacturing of Celestone Soluspan, collaborating with established CMOs. Such collaborations often include companies like Almac, Aenova Group, or Patheon—well-known for sterile and non-sterile pharmaceutical manufacturing.

2. Active Pharmaceutical Ingredient (API) Suppliers

The core of Celestone Soluspan’s supply chain revolves around sourcing high-quality APIs. These raw materials are critical for product efficacy, safety, and regulatory compliance.

• Global API Manufacturers:
  Many APIs used in niche or specialized drugs are sourced from large-scale producers in China, India, and Europe.

  • Sinopharm Group (China) and Shanghai Fosun Pharmaceutical are significant API suppliers in Asia, with extensive experience in complex molecules.
  • Sun Pharmaceutical Industries (India) is a prominent producer of active ingredients for various therapeutic areas.
  • Evonik Industries (Germany) and Johnson Matthey (UK) often supply complex or specialty APIs.

• Regulatory-Approved API Suppliers:
  Suppliers with pending or approved Drug Master Files (DMFs) with regulatory agencies such as FDA or EMA are preferred for compliance reasons. Companies like Novartis Technical Operations and BASF also provide APIs for global distribution.

3. Excipients and Packaging Components

Excipients influence formulation stability and bioavailability. Leading excipient suppliers include:

• Dow Chemical and Suzuki Corporation for binders, fillers, and diluents.
• BASF and JRS Pharma for stabilizers and functional excipients.

Packaging components—blister packs, bottles, and seals—are supplied by specialized packaging firms like Gerresheimer or Schott.

4. Distribution and Wholesale Suppliers

Distribution channels ensure Celestone Soluspan reaches global markets efficiently.

• McKesson and AmerisourceBergen: Major pharmaceutical distributors in North America.
• Alliance Healthcare and Phoenix Pharma (Europe) serve similar roles in Europe and emerging markets.

Regulatory and Supply Chain Considerations

Compliance with regulatory standards (e.g., FDA, EMA, PMDA) is paramount. Suppliers must maintain validated manufacturing processes, GMP certification, and quality assurance protocols. Geographic diversification reduces risks associated with political, logistical, or regulatory disruptions.

Emerging Trends in Supply Chain for Celestone Soluspan

The industry sees increasing adoption of digital supply chain management and blockchain for traceability. Biopharmaceuticals and complex formulations like Celestone Soluspan also drive outsourcing to specialized CMOs with expertise in sterile manufacturing.

Challenges and Risks

• Supply Disruptions: Natural disasters, geopolitical tensions, or pandemics (e.g., COVID-19) can impact critical raw material and API supply.
• Regulatory Non-Compliance: Suppliers lacking robust quality systems face risk of regulatory sanctions, product recalls, or delays.
• Intellectual Property (IP) Considerations: Proprietary formulations necessitate careful partner selection to protect IP rights.

Strategic Recommendations for Stakeholders

• Due Diligence: Regular audit and qualification of API and excipient suppliers ensure ongoing compliance.
• Diversification: Engage multiple suppliers across regions to mitigate supply risks.
• Collaborations: Foster partnerships with reputable CMOs experienced in the specific drug class.

Conclusion

The supply chain dynamic for Celestone Soluspan involves a complex network of API producers, excipient vendors, contract manufacturers, and distributors. While specific supplier identities remain proprietary or confidential, industry patterns suggest reliance on established regional leaders, particularly in API manufacturing within China, India, and Europe, complemented by global distributors. Strategic supplier relationships and adherence to regulatory standards are critical to ensuring supply continuity and product integrity.

---

Key Takeaways

• The supply chain for Celestone Soluspan hinges on a mix of API manufacturers, CMOs, and distributors, emphasizing quality and regulatory compliance.
• Asian API producers (China and India) dominate the raw materials landscape, with European firms providing specialty excipients and packaging components.
• Diversifying suppliers and employing rigorous qualification processes mitigate supply chain risks.
• Advances in digital supply chain management and quality assurance protocols enhance traceability and compliance.
• Stakeholders must continuously monitor geopolitical, regulatory, and market developments to adapt sourcing strategies effectively.

---

FAQs

Q1: Who are the primary API suppliers for Celestone Soluspan?

While specific API suppliers are proprietary, leading producers in China, India, and Europe are typical sources for complex pharmaceuticals like Celestone Soluspan.

Q2: Do regulatory agencies require disclosure of Celestone Soluspan’s suppliers?

Regulatory disclosures focus primarily on the manufacturer of the finished product and key excipients. Suppliers of APIs are often protected as proprietary information unless they are part of the regulatory submission under DMFs.

Q3: Can I identify Celestone Soluspan’s manufacturing partners publicly?

Publicly available data is limited; most manufacturing arrangements are confidential. Industry reports or regulatory filings may provide indirect clues.

Q4: What role do CMOs play in Celestone Soluspan’s supply chain?

CMOs are responsible for manufacturing the finished drug, ensuring quality, compliance, and scale-up capabilities, often under licensing or partnership agreements.

Q5: How do global supply chain disruptions impact Celestone Soluspan availability?

Disruptions in raw material or API supply chains can lead to delays or shortages, highlighting the importance of supply chain diversification and contingency planning.

---

Sources

1. U.S. Food and Drug Administration (FDA). Drug Master Files and regulatory guidelines.
2. Pharmaceutical Technology. Global API supplier reports.
3. GMP Compliance Guides. Industry standards for pharmaceutical manufacturing.
4. Industry Press Releases and Company Reports. Public disclosures by major API and excipient manufacturers.
5. Market Intelligence Reports. Trends in pharmaceutical supply chains.

Note: The above analysis synthesizes industry intelligence; specific supplier identities for Celestone Soluspan are proprietary and may not be publicly available.